Invitrogen Corp.
Invitrogen Corp. of Carlsbad, Calif.,
will acquire Phillipsburg, New Jersey-based Sentigen Holding Corp., a developer
of bioassay systems, in a cash transaction valued at $3.37 a share, or approximately
$25.9 million. With the purchase, the California company will expand its cellular
assay capabilities.
/Buyers_Guide/Invitrogen_Corp/c17557